<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091233</url>
  </required_header>
  <id_info>
    <org_study_id>2009/722</org_study_id>
    <nct_id>NCT01091233</nct_id>
  </id_info>
  <brief_title>The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study</brief_title>
  <official_title>The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with liver cirrhosis are at risk for development of renal failure, usually after a&#xD;
      precipitating event such as infection or bleeding. This form of renal failure has a high&#xD;
      morbidity and mortality and may be partly caused by increased intra-abdominal pressure&#xD;
      secondary to ascites. Recent studies have shown that paracentesis (and the resulting&#xD;
      decreased IAP) can increase urinary output and decrease renal arterial resistive index in&#xD;
      patients with hepatorenal syndrome (a very pronounced form of renal failure in cirrhosis&#xD;
      patients). The aim of this study is to evaluate the influence of Paracentesis on&#xD;
      intra-abdominal pressure and kidney function in critically ill patients with liver cirrhosis&#xD;
      and ascites across a wider range of kidney function. Kidney function will be evaluated using&#xD;
      several estimates of glomerular filtration rate and measures of kidney injury i.e. cystatin&#xD;
      C, serum NGAL, creatinine clearance, urinary output and renal arterial resistive index.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    logistical problems&#xD;
  </why_stopped>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-abdominal pressure and kidney function before, during, immediately after and 12-24h after Paracentesis</measure>
    <time_frame>24h after paracentesis</time_frame>
    <description>Kidney function parameters include 2h creatinine clearance, serum and urine creatinine, renal artery resistive index (measured via color Doppler), urinary output, serum cystatine C and NGAL measurement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The association between the change in IAP and kidney function</measure>
    <time_frame>24h after paracentesis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relationship between the amount of fluid drained and any effect on IAP and kidney function</measure>
    <time_frame>24h after paracentesis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cystatin C, NGAL, creatinine clearance, serum creatinine, urinary output and RI as measures of kidney injury in patients with liver cirrhosis and ascites</measure>
    <time_frame>24h after paracentesis</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Critically Ill</condition>
  <condition>Liver Cirrhosis</condition>
  <condition>Ascites</condition>
  <arm_group>
    <arm_group_label>Paracentesis</arm_group_label>
    <description>Paracentesis as indicated according to the treating physician (the indication for Paracentesis is not the subject of study)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>paracentesis</intervention_name>
    <description>as indicated according to the treating physician (the indication for Paracentesis is not the subject of study)</description>
    <arm_group_label>Paracentesis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill patients with liver cirrhosis and ascites requiring Paracentesis according&#xD;
        to treating physician&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  &gt;18 y old&#xD;
&#xD;
          -  Admitted to the ICU&#xD;
&#xD;
          -  Known liver cirrhosis with ascites on clinical examination and/or ultrasound&#xD;
&#xD;
          -  Sedated and mechanically ventilated&#xD;
&#xD;
          -  Paracentesis deemed necessary by treating physician&#xD;
&#xD;
          -  Arterial and central venous catheter in place&#xD;
&#xD;
          -  Urinary catheter in place&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Previous inclusion in the same study&#xD;
&#xD;
          -  Renal replacement therapy in place&#xD;
&#xD;
          -  Urinary catheter contra-indicated&#xD;
&#xD;
          -  Use of radiocontrast media within 72h before paracentesis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Hoste, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
    <description>website University Hospital Ghent</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 19, 2010</study_first_submitted>
  <study_first_submitted_qc>March 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2010</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Critically ill patients</keyword>
  <keyword>liver cirrhosis</keyword>
  <keyword>ascites requiring Paracentesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Ascites</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

